SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — Blacksmith Medicines, Inc. (Blacksmith), a leading biopharmaceutical company dedicated to discovering and developing therapeutics that target metalloenzymes, today announced the publication of research in the Journal of Medicinal Chemistry titled…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
